The Central Mumbai District Consumer Disputes Redressal Commission has held that an insurer cannot deny cashless pre-authorisation by treating an ailment that arose during a customer’s continuous insurance coverage as an undisclosed pre-existing disease, particularly when there is no established connection between that ailment and the condition for which treatment is sought. The case involved Mehul Gandhi, who had maintained a mediclaim policy with United India Insurance since 1996 before porting it to Care Health Insurance in September 2022. He paid a premium of ₹56,036 for a policy providing ₹25 lakh of coverage.
In December 2022, Gandhi was diagnosed with an intracranial aneurysm, for which surgery was estimated to cost around ₹20 lakh. When he sought cashless pre-authorisation, Care Health sought records relating to Bell’s Palsy in 2009 and a fainting episode in 2021. Gandhi’s doctor stated that the Bell’s Palsy had been treated at home and that the 2021 episode was a brief fainting reaction during blood collection. The insurer nevertheless rejected the cashless request on 6 January 2023, citing non-disclosure of Bell’s Palsy as a pre-existing condition.
The Commission noted that both the 2009 Bell’s Palsy and 2021 syncope occurred while Gandhi was continuously insured under the United India policy and therefore could not be treated as undisclosed pre-existing diseases when the policy was ported in 2022. It further found that merely recording a past medical history did not establish suppression of material facts. Importantly, the insurer did not produce expert evidence demonstrating a medical nexus between Bell’s Palsy and the intracranial aneurysm.
Want to deepen your expertise beyond today’s news?
Explore practical certification courses designed for banking, risk, insurance, compliance, ESG, AI, and emerging technologies professionals.
Learn from industry experts and earn certifications from RMAI and BFSI Sector Skill Council of India.
#Insurancenews

